Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human Serv”

1,157 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,157
Index total 30,257
Page 43 / 49

Quick answer

This filtered view shows 1,157 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,157 results for “The United States of America, as represented by the Secretary, Department of Health and Human Serv” · 30,257 patents in full index Clear search

  1. US 8637036

    Neutralizing antibodies to HIV-1 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  2. US 8636978

    Cyclized NGR peptide compounds, compositions, and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  3. US 8637050

    Peptide vaccines against group A streptococci

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  4. US 8637310

    Use of a rock inhibitor to sustain primary human keratinocytes in a proliferative state

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  5. US 8633177

    Nitroxyl (HNO) releasing compounds and uses thereof in treating diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  6. US 8632782

    Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  7. US 8628962

    Differentiation of stem cells into dopaminergic cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  8. US 8618090

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  9. US 8613932

    GP100-specific T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  10. US 8613933

    Brachyury polypeptides and methods for use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  11. US 8613934

    Cellular and viral inactivation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  12. US 8609395

    Agonist and antagonist peptides of carcinoembryonic antigen (CEA)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  13. US 8609716

    Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  14. US 8597660

    Therapeutic approach to neurodegenerative disorders using a TFP5-peptide

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  15. US 8597883

    Biomarkers for cancer-related fatigue and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  16. US 8597876

    Method of treating HIV infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  17. US 8580927

    Engineered antibody constant domain molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  18. US 8575375

    Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  19. US 8574853

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  20. US 8568739

    Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  21. US 8557788

    Prevention of tissue ischemia and related compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  22. US 8557844

    Substrate reduction therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  23. US 8556882

    Inducible interleukin-12

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  24. US 8551936

    Defensin-antigen fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.